Updates ·
Health notices · Saturday 14 November
3 notices from the agencies today, in plain words, each with the original linked.
Recall of metoclopramide tablets due to mixed contents
FDA · Recall
If you take metoclopramide tablets, the FDA has issued a Class II recall for certain bottles. The concern is tablet “co-mingling,” meaning tablets from different batches may have been mixed together.
This matters because taking a tablet that is not from the expected batch may increase the chance of getting the wrong product.
The recall notice was published on 2026-11-04 and says the product was distributed nationwide in the US. Check with your pharmacist or provider if you have this recalled metoclopramide.
The notice does not list specific steps for patients, so you should focus on confirming whether your bottle is affected.
FDA approval of glipizide and metformin hydrochloride tablets
FDA · Approval
If you have type 2 diabetes, the US Food and Drug Administration has approved a new oral tablet that combines glipizide and metformin hydrochloride.
The label says it is used as an adjunct to diet and exercise to help improve glycemic control, meaning blood sugar control.
If you’re taking medicines for type 2 diabetes, ask your clinician whether this specific tablet is appropriate for you. If so, your clinician will decide your treatment plan.
CDC updates C. diff educational resources
Centers for Disease Control and Prevention (CDC) · Guidance
If you’re looking for information on C. diff, the CDC has updated its educational resources (fact sheets, social media graphics, and animated videos) for the general public.
C. diff is a germ that can cause diarrhea and colitis (inflammation of the colon), and it can be life-threatening.
The update is aimed at helping people with basics, prevention, and caring for yourself and others, so you can better understand the illness and how to reduce risk.
Where this comes from
- Recall of metoclopramide tablets due to mixed contentsUS Food and Drug Administration — enforcement report
- FDA approval of glipizide and metformin hydrochloride tabletsUS Food and Drug Administration — Drugs@FDA
- CDC updates C. diff educational resourcesCenters for Disease Control and Prevention
Each notice above is summarised from the agency's own publication, linked beside it. Nothing here is a finding of ours.